ArticleMaedica2020
Interleukin-17 is Not Associated with Risk of Premature Coronary Artery Disease in Iranian Turks.
Article in Maedica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- IL-6 and lL-17 as potential biomarkers for premature coronary artery disease: a cross-sectional study.BMC cardiovascular disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular diseases are one of the most important causes of death globally. Results of recent studies have indicated that cytokine dysregulation was associated with premature coronary artery disease (P-CAD). The majority of cytokine gene polymorphisms influence the level of cytokine production and secretion. This study aimed to analyse IL-17 gene expression in patients with P-CAD and healty individuals in an Iranian population. This case-control study, conducted in Urmia University of Medical Sciences, compared patients with P-CAD hospitalised for risk of coronary artery stenosis, those admitted for medical cares and healthy normal controls. Thirty patients with P-CAD and 30 healthy individuals entered the study. The tested individulas were selected according to strict criteria such as clinical, echocardiogram, electrocardiogram and coronary angiography findings. Individuals with diabetes type 1 or 2 were excluded from the study. Reducing the diameter of at least one of the coronary arteries with more than 50% obstruction was selected as P-CAD. The qRT-PCR technique was used to determine the level of IL-17 gene expression in the studied groups. IL-17 gene expression was compared between the tested groups using t-test or Mann-Whitney U-test. Subjects' mean age (±SE) was 45(±5) and 44 (±4) among tested cases and related controls, respectively. The relative mRNA expression was 4.04±2.4 in patients with P-CAD and 2.75±1.3 in controls for IL-17. IL-17 gene expression was not significantly different in the tested groups (P> 0.05). IL-17 is not associated with risk of P-CAD in Iranian Turks.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.